Clinical Trial

Intra-Oral Treatment of OLP with Rivelin®-CLO Patches

Study Description

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

Participants with symptomatic Oral Lichen Planus lesions will be treated with RivelinAR patches containing either 0, 1, 5, or 20 I?g clobetasol per patch. Each participant will apply up to 6 patches twice daily for 4 weeks.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Clobetasol Propionate

Rivelin® patch is a two-layer patch comprised of a muco-adhesive, drug-delivery layer and a protective layer.

Additional Information

Official Study Title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate When Administered Intra-orally Twice Daily in Patients With Oral Lichen Planus (OLP) Using Rivelin®-CLO Patches

Clinical Trial ID

NCT03592342

ParticipAid ID

ejRRPe